You are here

Pharmaceutical-Approval Update: Oncology

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Three antineoplastic agents are described: intravenous cetuximab for metastatic colorectal cancer, injected pemetrexed for malignant pleural mesothelioma, and injected oxaliplatin for recurrent or metastatic colorectal cancer.